Rituximab therapy leads to reduced imprints of receptor revision in immunoglobulin κ and λ light chains

Journal of Rheumatology

Volumn 39, Issue 6, 2012, Pages 1130-1138

  Palanichamy, Arumugam ^a   Muhammad, Khalid ^a   Roll, Petra ^a   Kleinert, Stefan ^a   Dörner, Thomas ^b   Tony, Hans Peter ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Immunoglobulin light chains; Receptor revision; Rheumatoid arthritis

Indexed keywords

CD27 ANTIGEN; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN LAMBDA CHAIN; RITUXIMAB;

ADULT; ARTICLE; B LYMPHOCYTE; CASE REPORT; CELL REGENERATION; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; GENE CASSETTE; GENE REARRANGEMENT; GENOME IMPRINTING; HUMAN; HUMAN CELL; IMMUNOGLOBULIN GENE; MEMORY CELL; PRIORITY JOURNAL; RECEPTOR REVISION; RHEUMATOID ARTHRITIS; SINGLE DRUG DOSE; SOMATIC HYPERMUTATION;

ADULT; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTIRHEUMATIC AGENTS; B-LYMPHOCYTE SUBSETS; FEMALE; GENE REARRANGEMENT, B-LYMPHOCYTE, LIGHT CHAIN; GENES, IMMUNOGLOBULIN; GERMINAL CENTER; HUMANS; IMMUNOGLOBULIN CLASS SWITCHING; IMMUNOGLOBULIN KAPPA-CHAINS; IMMUNOGLOBULIN LAMBDA-CHAINS; IMMUNOLOGIC MEMORY; MIDDLE AGED; RECEPTORS, ANTIGEN, B-CELL;

EID: 84861793564     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.111513     Document Type: Article

References (36)

1. Firestein GS. Evolving concepts of rheumatoid arthritis. Nature 2003;423:356-61. (Pubitemid 40852711)
2. Marston B, Palanichamy A, Anolik JH. B cells in the pathogenesis and treatment of rheumatoid arthritis. Curr Opin Rheumatol 2010;22:307-15.
3. Takemura S, Klimiuk PA, Braun A, Goronzy JJ, Weyand CM. T cell activation in rheumatoid synovium is B cell dependent. J Immunol 2001;167:4710-8. (Pubitemid 32954353)
4. Dorner T. Crossroads of B cell activation in autoimmunity: Rationale of targeting B cells. J Rheumatol Suppl. 2006 May;77:3-11.
5. Hansen A, Lipsky PE, Dorner T. B-cell lymphoproliferation in chronic inflammatory rheumatic diseases. Nat Clin Pract Rheumatol 2007;3:561-9. (Pubitemid 47514471)
6. Dorner T, Lipsky PE. Molecular basis of immunoglobulin variable region gene usage in systemic autoimmunity. Clin Exp Med 2005;4:159-69. (Pubitemid 40562033)
7. Edwards JC, Szczepanski L, Szechinski J, Filipowicz-Sosnowska A, Emery P, Close DR, et al. Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. N Engl J Med 2004;350:2572-81. (Pubitemid 38758544)
8. Roll P, Palanichamy A, Kneitz C, Dorner T, Tony HP. Regeneration of B cell subsets after transient B cell depletion using anti-CD20 antibodies in rheumatoid arthritis. Arthritis Rheum 2006; 54:2377-86. (Pubitemid 44204997)
9. Anolik JH, Friedberg JW, Zheng B, Barnard J, Owen T, Cushing E, et al. B cell reconstitution after rituximab treatment of lymphoma recapitulates B cell ontogeny. Clin Immunol 2007;122:139-45. (Pubitemid 46073890)
10. Wardemann H, Yurasov S, Schaefer A, Young JW, Meffre E, Nussenzweig MC. Predominant autoantibody production by early human B cell precursors. Science 2003;301:1374-7. (Pubitemid 37075812)
11. Morbach H, Richl P, Faber C, Singh SK, Girschick HJ. The kappa immunoglobulin light chain repertoire of peripheral blood B cells in patients with juvenile rheumatoid arthritis. Mol Immunol 2008;45:3840-6.
12. Halverson R, Torres RM, Pelanda R. Receptor editing is the main mechanism of B cell tolerance toward membrane antigens. Nature Immunol 2004;5:645-50. (Pubitemid 38811890)
13. Samuels J, Ng YS, Coupillaud C, Paget D, Meffre E. Impaired early B cell tolerance in patients with rheumatoid arthritis. J Exp Med 2005;201:1659-67. (Pubitemid 40721009)
14. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24. (Pubitemid 18091653)
15. Palanichamy A, Roll P, Theiss R, Dorner T, Tony HP. Modulation of molecular imprints in the antigen-experienced B cell repertoire by rituximab. Arthritis Rheum 2008;58:3665-74.
16. Frolich D, Giesecke C, Mei HE, Reiter K, Daridon C, Lipsky PE, et al. Secondary immunization generates clonally related antigen-specific plasma cells and memory B cells. J Immunol 2010;185:3103-10.
17. Brezinschek HP, Foster SJ, Dorner T, Brezinschek RI, Lipsky PE. Pairing of variable heavy and variable kappa chains in individual naive and memory B cells. J Immunol 1998;160:4762-7. (Pubitemid 28215309)
18. Farner NL, Dorner T, Lipsky PE. Molecular mechanisms and selection influence the generation of the human V lambda J lambda repertoire. J Immunol 1999;162:2137-45. (Pubitemid 29288835)
19. Souto-Carneiro MM, Longo NS, Russ DE, Sun HW, Lipsky PE. Characterization of the human Ig heavy chain antigen binding complementarity determining region 3 using a newly developed software algorithm, JOINSOLVER. J Immunol 2004;172:6790-802. (Pubitemid 38669117)
20. Frippiat JP, Williams SC, Tomlinson IM, Cook GP, Cherif D, Le Paslier D, et al. Organization of the human immunoglobulin lambda light-chain locus on chromosome 22q11.2. Human Mol Genet 1995;4:983-91.
21. Lindholm C, Borjesson-Asp K, Zendjanchi K, Sundqvist AC, Tarkowski A, Bokarewa M. Longterm clinical and immunological effects of anti-CD20 treatment in patients with refractory systemic lupus erythematosus. J Rheumatol 2008;35:826-33. (Pubitemid 351747123)
22. Muhammad K, Roll P, Einsele H, Dorner T, Tony HP. Delayed acquisition of somatic hypermutations in repopulated IGD+CD27+ memory B cell receptors after rituximab treatment. Arthritis Rheum 2009;60:2284-93.
23. Rouziere AS, Kneitz C, Palanichamy A, Dorner T, Tony HP. Regeneration of the immunoglobulin heavy-chain repertoire after transient B-cell depletion with an anti-CD20 antibody. Arthritis Res Ther 2005;7:R714-24.
24. Pyon HS, Ha-Lee YM, Song GG, Sohn J. Analysis of Ig kappa light chain gene variable regions expressed in the rheumatoid synovial B cells. Scand J Immunol 2001;53:503-9. (Pubitemid 32382275)
25. Dorner T, Foster SJ, Farner NL, Lipsky PE. Immunoglobulin kappa chain receptor editing in systemic lupus erythematosus. J Clin Invest 1998;102:688-94. (Pubitemid 28399600)
26. Meffre E, Davis E, Schiff C, Cunningham-Rundles C, Ivashkiv LB, Staudt LM, et al. Circulating human B cells that express surrogate light chains and edited receptors. Nat Immunol 2000;1:207-13.
27. Prak EL, Weigert M. Light chain replacement: A new model for antibody gene rearrangement. J Exp Med 1995;182:541-8.
28. Foster SJ, Brezinschek HP, Brezinschek RI, Lipsky PE. Molecular mechanisms and selective influences that shape the kappa gene repertoire of IgM+ B cells. J Clin Invest 1997;99:1614-27. (Pubitemid 27163812)
29. Gauss GH, Lieber MR. The basis for the mechanistic bias for deletional over inversional V(D)J recombination. Genes Dev 1992;6:1553-61.
30. Dorner T, Farner NL, Lipsky PE. Ig lambda and heavy chain gene usage in early untreated systemic lupus erythematosus suggests intensive B cell stimulation. J Immunol 1999;163:1027-36. (Pubitemid 29328116)
31. Lee J, Monson NL, Lipsky PE. The V lambda J lambda repertoire in human fetal spleen: Evidence for positive selection and extensive receptor editing. J Immunol 2000;165:6322-33.
32. Mei HE, Frolich D, Giesecke C, Loddenkemper C, Reiter K, Schmidt S, et al. Steady-state generation of mucosal IgA+ plasmablasts is not abrogated by B-cell depletion therapy with rituximab. Blood 2010;116:5181-90.
33. Hoyer BF, Moser K, Hauser AE, Peddinghaus A, Voigt C, Eilat D, et al. Short-lived plasmablasts and long-lived plasma cells contribute to chronic humoral autoimmunity in NZB/W mice. J Exp Med 2004;199:1577-84. (Pubitemid 38780412)
34. Dorner T, Foster SJ, Brezinschek HP, Lipsky PE. Analysis of the targeting of the hypermutational machinery and the impact of subsequent selection on the distribution of nucleotide changes in human VHDJH rearrangements. Immunol Rev 1998;162:161-71. (Pubitemid 28182133)
35. Foster SJ, Dorner T, Lipsky PE. Somatic hypermutation of V kappa J kappa rearrangements: Targeting of RGYW motifs on both DNA strands and preferential selection of mutated codons within RGYW motifs. Eur J Immunol 1999;29:4011-21.
36. Monson NL, Dorner T, Lipsky PE. Targeting and selection of mutations in human V lambda rearrangements. Eur J Immunol 2000;30:1597-605. (Pubitemid 30342801)